Related Experiment Video
Updated: Jun 7, 2025

09:04
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
8.2K
Single-stranded DNA with internal base modifications mediates highly efficient knock-in in primary cells using
Karen L Kanke1, Rachael E Rayner2, Jack Bozik1
1Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43215, USA.
Nucleic Acids Research
|November 21, 2024
Summary
Chemically modified single-stranded DNA (ssDNA) significantly enhances genome knock-in efficiency in various primary cells. This optimized ssDNA approach shows therapeutic potential for genetic disorders.
Area of Science:
- Molecular Biology
- Gene Editing
- Genomics
Background:
- Single-stranded DNA (ssDNA) and Cas9 are used for genome knock-in but efficiency is often low.
- Chemical modifications to ssDNA can potentially improve gene editing outcomes.
Purpose of the Study:
- To investigate the efficacy of internally chemically modified ssDNA (esDNA) for enhancing genome knock-in efficiency.
- To compare esDNA performance against end-modified ssDNA in various cell types.
Main Methods:
- Development and application of enhanced ssDNA (esDNA) with 12-19% internal base chemical modifications.
- Testing esDNA for knock-in (KI) efficiency in airway basal stem cells (ABCs), CD34+ hematopoietic cells, T-cells, and endothelial cells.
- Investigating the role of TREX1 nuclease in esDNA-mediated KI, including knockout experiments.
Main Results:
- esDNA improved KI efficiency by 2-3 fold compared to end-modified ssDNA in multiple primary cell types.
- Achieved over 50% allele KI in clinically relevant loci (CFTR, HBB, CCR5) in ABCs.
- Demonstrated up to 70% allele KI in the HBB locus in CD34+ cells with a DNA-PKcs inhibitor.
- esDNA did not improve KI in induced pluripotent stem cells (iPSCs), potentially due to TREX1 absence.
- TREX1 knockout enhanced KI with unmodified ssDNA in other cell types.
Conclusions:
- Internally modified ssDNA (esDNA) represents a significant advancement for enhancing genome knock-in in primary cells.
- This method offers therapeutically relevant correction levels, comparable to AAV-based methods.
- The findings suggest TREX1 plays a crucial role in ssDNA-mediated gene editing, opening avenues for further optimization.
- esDNA is suitable for modifying small genomic regions (20-30 bp) in primary cells for therapeutic and research applications.
Related Concept Videos
CRISPR
49.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.5K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K

